ToxoTech develops advanced botulinum toxin therapies targeting neuromuscular and neurological disorders. Their innovative approach aims to improve efficacy, safety, and precision, offering enhanced therapeutic options for patients and healthcare providers, and driving new possibilities in clinical treatment of muscle-related and neurological conditions.